✦ LIBER ✦

249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency

✍ Scribed by A. Zuckermann; A. Keogh; M.G. Crespo-Leiro; D. Mancini; F. Gonzalez-Vilchez; L. Almenar; S. Brozena; H. Eisen; S. See Tai; S. Kashwaha

Book ID: 116522296
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 65 KB
Volume: 29
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2009.11.260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

56 Safety and Efficacy of Conversion to

56 Safety and Efficacy of Conversion to Sirolimus vs Continued Calcineurin Inhibitor Use in Cardiac Transplant Recipients with Renal Insufficiency

✍ A. Zuckermann; A. Keogh; M.G. Crespo-Leiro; D. Mancini; F. Gonzalez Vilchez; L. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 167 KB

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

An open-label, pilot study evaluating th

An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency

✍ V Ram Peddi; Stephen Jensik; Mark Pescovitz; John Pirsch; Scott H Adler; J Richa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency

✍ Nassim Kamar; Luc Frimat; Gilles Blancho; Philippe Wolff; Michel Delahousse; Lio 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 482 KB

Study 1: an open-label pilot study evalu

Study 1: an open-label pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in renal allograft recipients on a regimen of maintenance therapy with moderate renal insufficiency

✍ V.Ram Peddi; David J. Cohen; M.Roy First 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB